LeMaitre Vascular (LMAT)Director sold ~$91K

~$91K

Approx. value · 976 sh @ $92.78

4,773

Holds after · shares reported

Traded

Aug 12, 2025

Filed

Aug 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 6, 2025InsiderCEO sold ~$9.35M of LMAT shares in the open market
2. Aug 8, 2025Insider · 2 peopleInsiders: 2 sales (~$323K)
3. Aug 11, 2025Insider · 2 peopleInsiders: 5 sales (~$1.6M)
4. Aug 12, 2025 · this disclosureInsiderDirector sold ~$91K of LMAT shares in the open market

What came next

1. Oct 11, 2025Federal contract · $24K obligatedDepartment of Veterans Affairs awarded LEMAITRE VASCULAR INC: $24K obligated to date
2. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
3. Nov 19, 2025Federal contract · $12K obligatedDepartment of Veterans Affairs awarded LEMAITRE VASCULAR INC: $12K obligated to date

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for LeMaitre Vascular

For LeMaitre Vascular, OQRO holds 5 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LMAT page.

Other recent filings by Lawrence J Jasinski, Director

• SEC Form 4 at Lifeward (LFWD)May 22, 2025
• SEC Form 4 at LeMaitre Vascular (LMAT)Mar 6, 2025
• SEC Form 4 at LeMaitre Vascular (LMAT)Nov 22, 2024

The full history of Lawrence J Jasinski, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at LeMaitre Vascular

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• USAspending.gov award recordAug 5, 2026
• SEC Form 13F-HRAug 4, 2026
• SEC Form 13F-HRJul 24, 2026

Everything OQRO holds on this company is on its LMAT page.